Developing Compelling Global Health Policy Narratives and Supporting Evidence

As a part of its global therapeutic area (TA) health policy initiatives, a leading biopharma company needed a new and improved narrative and evidence deck to impress upon policymakers and other critical stakeholders the importance of timely diagnosis and treatment of a specific disease. The materials were structured in three sections:

  1. Making the case for change for policy makers
  2. Giving reasons to believe effective policy solutions are available
  3. Issuing a call to action by policy makers

BTG delivered a senior health policy consultant to analyze the current research and materials to better understand the burden and impact of the disease. The consultant then created a TA-specific health policy narrative for both U.S. and ex-U.S. markets, developed a one-page leave-behind tailored to each market, and built an external evidence deck for presentation at regional franchise meetings.

We take our clients' confidentiality seriously. We've changed their names, but the results are real. For further details, email us at info@businesstalentgroup.com or complete the Learn More form on this page.